[Skip to Content]
[Skip to Content Landing]

Screening for Anxiety in Children and AdolescentsEvidence Report and Systematic Review for the US Preventive Services Task Force

To identify the key insights or developments described in this article
1 Credit CME
Abstract

Importance  Anxiety in children and adolescents is associated with impaired functioning, educational underachievement, and future mental health conditions.

Objective  To review the evidence on screening for anxiety in children and adolescents to inform the US Preventive Services Task Force.

Data Sources  PubMed, Cochrane Library, PsycINFO, CINAHL, and trial registries through July 19, 2021; references, experts, and surveillance through June 1, 2022.

Study Selection  English-language, randomized clinical trials (RCTs) of screening; diagnostic test accuracy studies; RCTs of cognitive behavioral therapy (CBT) or US Food and Drug Administration–approved pharmacotherapy; RCTs, observational studies, and systematic reviews reporting harms.

Data Extraction and Synthesis  Two reviewers assessed titles/abstracts, full-text articles, and study quality and extracted data; when at least 3 similar studies were available, meta-analyses were conducted.

Main Outcomes and Measures  Test accuracy, symptoms, response, remission, loss of diagnosis, all-cause mortality, functioning, suicide-related symptoms or events, adverse events.

Results  Thirty-nine studies (N = 6065) were included. No study reported on the direct benefits or harms of screening on health outcomes. Ten studies (n = 3260) reported the sensitivity of screening instruments, ranging from 0.34 to 1.00, with specificity ranging from 0.47 to 0.99. Twenty-nine RCTs (n = 2805) reported on treatment: 22 on CBT, 6 on pharmacotherapy, and 1 on CBT, sertraline, and CBT plus sertraline. CBT was associated with gains on several pooled measures of symptom improvement (magnitude of change varied by outcome measure), response (pooled relative risk [RR], 1.89 [95% CI, 1.17 to 3.05]; n = 606; 6 studies), remission (RR, 2.68 [95% CI, 1.48 to 4.88]; n = 321; 4 studies), and loss of diagnosis (RR range, 3.02-3.09) when compared with usual care or wait-list controls. The evidence on functioning for CBT was mixed. Pharmacotherapy, when compared with placebo, was associated with gains on 2 pooled measures of symptom improvement—mean difference (Pediatric Anxiety Rating Scale mean difference, −4.0 [95% CI, −5.5 to −2.5]; n = 726; 5 studies; and Clinical Global Impression–Severity scale mean difference, −0.84 [95% CI, −1.13 to −0.55]; n = 550; 4 studies) and response (RR, 2.11 [95% CI, 1.58 to 2.98]; n = 370; 5 studies)—but was mixed on measures of functioning. Eleven RCTs (n = 1293) reported harms of anxiety treatments. Suicide-related harms were rare, and the differences were not statistically significantly different.

Conclusions and Relevance  Indirect evidence suggested that some screening instruments were reasonably accurate. CBT and pharmacotherapy were associated with benefits; no statistically significant association with harms was reported.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Corresponding Author: Meera Viswanathan, PhD, RTI International, 3040 E Cornwallis Rd, Research Triangle Park, NC 27709 (viswanathan@rti.org).

Accepted for Publication: August 25, 2022.

Author Contributions: Dr Viswanathan had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Viswanathan, Kahwati.

Acquisition, analysis, or interpretation of data: Viswanathan, Wallace, Cook Middleton, Kennedy, McKeeman, Hudson, Rains, Vander Schaaf, Kahwati.

Drafting of the manuscript: Viswanathan, Kennedy, Rains.

Critical revision of the manuscript for important intellectual content: Viswanathan, Wallace, Cook Middleton, Kennedy, McKeeman, Hudson, Rains, Vander Schaaf, Kahwati.

Statistical analysis: Viswanathan, Wallace, Kahwati.

Obtained funding: Viswanathan, Kahwati.

Administrative, technical, or material support: Viswanathan, Kennedy, Rains.

Supervision: Viswanathan.

Conflict of Interest Disclosures: Dr Vander Schaaf reported that she is a Fellow of the American Academy of Pediatrics and member of American Academy of Pediatrics CATCH Committee. No other disclosures were reported.

Funding/Support: This study was funded under contract HHSA-290-2015-00011-I, Task Order 15, and Contract 75Q80120D00007, Task Order 05, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services (HHS), under a contract to support the US Preventive Services Task Force (USPSTF).

Role of the Funder/Sponsor: Investigators worked with USPSTF members and AHRQ staff to develop the scope, analytic framework, and key questions for this review. AHRQ had no role in study selection, quality assessment, or synthesis. AHRQ staff provided project oversight, reviewed the report to ensure that the analysis met methodological standards, and distributed the draft for peer review. Otherwise, AHRQ had no role in the conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript findings. The opinions expressed in this document are those of the authors and do not represent the official position of AHRQ or HHS.

Additional Contributions: We acknowledge the following individuals for their contributions to this project: AHRQ staff Iris Mabry-Hernandez, MD, MPH, and Tracy Wolf, MD, MPH; current and former members of the USPSTF who contributed to topic deliberations; and RTI International–University of North Carolina Evidence-based Practice Center staff Christiane Voisin, MSLS, Candi Wines, MPH, Nila A. Sathe, MA, MLIS, Carol Woodell, BSPH, Sharon Barrell, MA, Staci Rachman, BA, Sarah Barringer, Michelle Bogus, Teyonna Downing, and Loraine Monroe. USPSTF members, peer reviewers, and federal partner reviewers did not receive financial compensation for their contributions.

Additional Information: A draft version of the full evidence report underwent external peer review from 4 content experts (Gregory Simon, MD, MPH, University of Washington; Joan Asarnow, PhD, University of California, Los Angeles; Natalie Cort, PhD, William James College; and Raquel Halfond, PhD, American Psychological Association) and 1 federal partner reviewer (Erin Abramsohn, DrPH, Centers for Disease Control and Prevention). Comments from reviewers were presented to the USPSTF during its deliberation of the evidence and were considered by the authors in preparing the final evidence review.

Editorial Disclaimer: This evidence report is presented as a document in support of the accompanying USPSTF recommendation statement. It did not undergo additional peer review after submission to JAMA.

References
1.
US Department of Commerce.  2020 National Survey of Children’s Health: Topical Frequencies. US Census Bureau; 2021.
2.
Beesdo  K , Bittner  A , Pine  DS ,  et al.  Incidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life.   Arch Gen Psychiatry. 2007;64(8):903-912. doi:10.1001/archpsyc.64.8.903PubMedGoogle ScholarCrossref
3.
Beesdo-Baum  K , Höfler  M , Gloster  AT ,  et al.  The structure of common mental disorders: a replication study in a community sample of adolescents and young adults.   Int J Methods Psychiatr Res. 2009;18(4):204-220. doi:10.1002/mpr.293PubMedGoogle ScholarCrossref
4.
Tandon  M , Cardeli  E , Luby  J .  Internalizing disorders in early childhood: a review of depressive and anxiety disorders.   Child Adolesc Psychiatr Clin N Am. 2009;18(3):593-610. doi:10.1016/j.chc.2009.03.004PubMedGoogle ScholarCrossref
5.
Bittner  A , Egger  HL , Erkanli  A , Jane Costello  E , Foley  DL , Angold  A .  What do childhood anxiety disorders predict?   J Child Psychol Psychiatry. 2007;48(12):1174-1183. doi:10.1111/j.1469-7610.2007.01812.xPubMedGoogle ScholarCrossref
6.
Ezpeleta  L , Keeler  G , Erkanli  A , Costello  EJ , Angold  A .  Epidemiology of psychiatric disability in childhood and adolescence.   J Child Psychol Psychiatry. 2001;42(7):901-914. doi:10.1111/1469-7610.00786PubMedGoogle ScholarCrossref
7.
Copeland  WE , Angold  A , Shanahan  L , Costello  EJ .  Longitudinal patterns of anxiety from childhood to adulthood: the Great Smoky Mountains Study.   J Am Acad Child Adolesc Psychiatry. 2014;53(1):21-33. doi:10.1016/j.jaac.2013.09.017PubMedGoogle ScholarCrossref
8.
Woodward  LJ , Fergusson  DM .  Life course outcomes of young people with anxiety disorders in adolescence.   J Am Acad Child Adolesc Psychiatry. 2001;40(9):1086-1093. doi:10.1097/00004583-200109000-00018PubMedGoogle ScholarCrossref
9.
US Preventive Services Task Force. US Preventive Services Task Force Procedure Manual. Published 2021. Accessed August 16, 2022. https://www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-vi-criteria-assessing-internal-validity-individual-studies
10.
Viswanathan  M , Wallace  I , Cook Middleton  J ,  et al.  Screening for Depression, Anxiety, and Suicide Risk in Children and Adolescents: An Evidence Review for the US Preventive Services Task Force. Evidence Synthesis No. 221. Agency for Healthcare Research and Quality; 2022. AHRQ publication 22-05293-EF-1.
11.
Wang  Z , Whiteside  S , Sim  L ,  et al. Anxiety In Children. Report No. 17-EHC023-EF. Comparative Effectiveness Reviews No. 192. Agency for Healthcare Research and Quality. Published 2017. Accessed August 31, 2022. https://www.effectivehealthcare.ahrq.gov/reports/final.cfm
12.
United Nations Development Programme. Human Development Report 2019: Beyond Income, Beyond Averages, Beyond Today: Inequalities in Human Development in the 21st Century. Published 2019. Accessed August 31, 2022. https://hdr.undp.org/content/human-development-report-2019
13.
Sterne  JAC , Savović  J , Page  MJ ,  et al.  RoB 2: a revised tool for assessing risk of bias in randomised trials.   BMJ. 2019;366:l4898. doi:10.1136/bmj.l4898PubMedGoogle ScholarCrossref
14.
Sterne  JA , Hernán  MA , Reeves  BC ,  et al.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.   BMJ. 2016;355:i4919. doi:10.1136/bmj.i4919PubMedGoogle ScholarCrossref
15.
Whiting  P , Savović  J , Higgins  JP ,  et al; ROBIS Group.  ROBIS: a new tool to assess risk of bias in systematic reviews was developed.   J Clin Epidemiol. 2016;69:225-234. doi:10.1016/j.jclinepi.2015.06.005PubMedGoogle ScholarCrossref
16.
Whiting  PF , Rutjes  AW , Westwood  ME ,  et al; QUADAS-2 Group.  QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.   Ann Intern Med. 2011;155(8):529-536. doi:10.7326/0003-4819-155-8-201110180-00009PubMedGoogle ScholarCrossref
17.
Comprehensive Meta-analysis. Version 3. Biostat; 2013. Accessed September 16, 2022. https://www.meta-analysis.com/
18.
Deeks  J , Higgins  J , Altman  DG ; Cochrane Statistical Methods Group. Analysing data and undertaking meta-analyses. In: Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, Welch V, eds. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane. Published 2022. Accessed August 31, 2022. https://training.cochrane.org/handbook
19.
US Preventive Services Task Force. US Preventive Services Task Force Procedure Manual: appendix VI: criteria for assessing internal validity of individual studies. Published 2017. https://www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-vi-criteria-assessing-internal-validity-individual-studies
20.
Viswanathan  M , Wallace  IF , Cook Middleton  JC ,  et al.  Screening for depression and suicide risk in children and adolescents: updated evidence report and systematic review for the US Preventive Services Task Force.   JAMA. Published online October 11, 2022. doi:10.1001/jama.2022.16310Google Scholar
21.
Bailey  KA , Chavira  DA , Stein  MT , Stein  MB .  Brief measures to screen for social phobia in primary care pediatrics.   J Pediatr Psychol. 2006;31(5):512-521. doi:10.1093/jpepsy/jsj044PubMedGoogle ScholarCrossref
22.
Canals  J , Hernández-Martínez  C , Cosi  S , Domènech  E .  Examination of a cutoff score for the Screen for Child Anxiety Related Emotional Disorders (SCARED) in a non-clinical Spanish population.   J Anxiety Disord. 2012;26(8):785-791. doi:10.1016/j.janxdis.2012.07.008PubMedGoogle ScholarCrossref
23.
Garcia-Lopez  LJ , Sáez-Castillo  AJ , Beidel  D , La Greca  AM .  Brief measures to screen for social anxiety in adolescents.   J Dev Behav Pediatr. 2015;36(8):562-568. doi:10.1097/DBP.0000000000000213PubMedGoogle ScholarCrossref
24.
Johnson  JG , Harris  ES , Spitzer  RL , Williams  JBW .  The patient health questionnaire for adolescents: validation of an instrument for the assessment of mental disorders among adolescent primary care patients.   J Adolesc Health. 2002;30(3):196-204. doi:10.1016/S1054-139X(01)00333-0PubMedGoogle ScholarCrossref
25.
Muris  P , Merckelbach  H , Kindt  M ,  et al.  The utility of Screen for Child Anxiety Related Emotional Disorders (SCARED) as a tool for identifying children at high risk for prevalent anxiety disorders.   Anxiety Stress Coping. 2001;14(3):265-283. doi:10.1080/10615800108248357Google ScholarCrossref
26.
O’Connor  S , Ferguson  E , Carney  T , House  E , O’Connor  RC .  The development and evaluation of the paediatric index of emotional distress (PI-ED).   Soc Psychiatry Psychiatr Epidemiol. 2016;51(1):15-26. doi:10.1007/s00127-015-1134-yPubMedGoogle ScholarCrossref
27.
Queen  AH , Ehrenreich-May  J , Hershorin  ER .  Preliminary validation of a screening tool for adolescent panic disorder in pediatric primary care clinics.   Child Psychiatry Hum Dev. 2012;43(2):171-183. doi:10.1007/s10578-011-0256-zPubMedGoogle ScholarCrossref
28.
Ranta  K , Kaltiala-Heino  R , Rantanen  P , Tuomisto  MT , Marttunen  M .  Screening social phobia in adolescents from general population: the validity of the Social Phobia Inventory (SPIN) against a clinical interview.   Eur Psychiatry. 2007;22(4):244-251. doi:10.1016/j.eurpsy.2006.12.002PubMedGoogle ScholarCrossref
29.
Ranta  K , Kaltiala-Heino  R , Rantanen  P , Marttunen  M .  The Mini-Social Phobia Inventory: psychometric properties in an adolescent general population sample.   Compr Psychiatry. 2012;53(5):630-637. doi:10.1016/j.comppsych.2011.07.007PubMedGoogle ScholarCrossref
30.
Tsai  CF , Wang  SJ , Juang  KD , Fuh  JL .  Use of the Chinese (Taiwan) version of the Social Phobia Inventory (SPIN) among early adolescents in rural areas: reliability and validity study.   J Chin Med Assoc. 2009;72(8):422-429. doi:10.1016/S1726-4901(09)70399-5PubMedGoogle ScholarCrossref
31.
Ishikawa  SI , Kikuta  K , Sakai  M , Mitamura  T , Motomura  N , Hudson  JL .  A randomized controlled trial of a bidirectional cultural adaptation of cognitive behavior therapy for children and adolescents with anxiety disorders.   Behav Res Ther. 2019;120:103432. doi:10.1016/j.brat.2019.103432PubMedGoogle ScholarCrossref
32.
Walkup  JT , Albano  AM , Piacentini  J ,  et al.  Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.   N Engl J Med. 2008;359(26):2753-2766. doi:10.1056/NEJMoa0804633PubMedGoogle ScholarCrossref
33.
Albano  AM , Comer  JS , Compton  SN ,  et al.  Secondary outcomes from the child/adolescent anxiety multimodal study: implications for clinical practice.   Evid Based Pract Child Adolesc Ment Health. 2018;3(1):30-41. doi:10.1080/23794925.2017.1399485PubMedGoogle ScholarCrossref
34.
Taylor  JH , Lebowitz  ER , Jakubovski  E , Coughlin  CG , Silverman  WK , Bloch  MH .  Monotherapy insufficient in severe anxiety? predictors and moderators in the child/adolescent anxiety multimodal study.   J Clin Child Adolesc Psychol. 2018;47(2):266-281. doi:10.1080/15374416.2017.1371028PubMedGoogle ScholarCrossref
35.
Compton  SN , Peris  TS , Almirall  D ,  et al.  Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trial.   J Consult Clin Psychol. 2014;82(2):212-224. doi:10.1037/a0035458PubMedGoogle ScholarCrossref
36.
Caporino  NE , Read  KL , Shiffrin  N ,  et al.  Sleep-related problems and the effects of anxiety treatment in children and adolescents.   J Clin Child Adolesc Psychol. 2017;46(5):675-685. doi:10.1080/15374416.2015.1063429PubMedGoogle ScholarCrossref
37.
Sanchez  AL , Comer  JS , Coxe  S ,  et al.  The effects of youth anxiety treatment on school impairment: differential outcomes across CBT, sertraline, and their combination.   Child Psychiatry Hum Dev. 2019;50(6):940-949. doi:10.1007/s10578-019-00896-3PubMedGoogle ScholarCrossref
38.
Rynn  MA , Walkup  JT , Compton  SN ,  et al.  Child/adolescent anxiety multimodal study: evaluating safety.   J Am Acad Child Adolesc Psychiatry. 2015;54(3):180-190. doi:10.1016/j.jaac.2014.12.015PubMedGoogle ScholarCrossref
39.
Gordon-Hollingsworth  AT , Becker  EM , Ginsburg  GS ,  et al.  Anxiety disorders in Caucasian and African American children: a comparison of clinical characteristics, treatment process variables, and treatment outcomes.   Child Psychiatry Hum Dev. 2015;46(5):643-655. doi:10.1007/s10578-014-0507-xPubMedGoogle ScholarCrossref
40.
Ginsburg  GS , Kendall  PC , Sakolsky  D ,  et al.  Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS.   J Consult Clin Psychol. 2011;79(6):806-813. doi:10.1037/a0025933PubMedGoogle ScholarCrossref
41.
Strawn  JR , Prakash  A , Zhang  Q ,  et al.  A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder.   J Am Acad Child Adolesc Psychiatry. 2015;54(4):283-293. doi:10.1016/j.jaac.2015.01.008PubMedGoogle ScholarCrossref
42.
Salzer  S , Stefini  A , Kronmüller  KT ,  et al.  Cognitive-behavioral and psychodynamic therapy in adolescents with social anxiety disorder: a multicenter randomized controlled trial.   Psychother Psychosom. 2018;87(4):223-233. doi:10.1159/000488990PubMedGoogle ScholarCrossref
43.
Stjerneklar  S , Hougaard  E , McLellan  LF , Thastum  M .  A randomized controlled trial examining the efficacy of an internet-based cognitive behavioral therapy program for adolescents with anxiety disorders.   PLoS One. 2019;14(9):e0222485. doi:10.1371/journal.pone.0222485PubMedGoogle ScholarCrossref
44.
Cornacchio  D , Furr  JM , Sanchez  AL ,  et al.  Intensive group behavioral treatment (IGBT) for children with selective mutism: a preliminary randomized clinical trial.   J Consult Clin Psychol. 2019;87(8):720-733. doi:10.1037/ccp0000422PubMedGoogle ScholarCrossref
45.
Cobham  VE , Filus  A , Sanders  MR .  Working with parents to treat anxiety-disordered children: a proof of concept RCT evaluating Fear-less Triple P.   Behav Res Ther. 2017;95:128-138. doi:10.1016/j.brat.2017.06.004PubMedGoogle ScholarCrossref
46.
Ginsburg  GS , Pella  JE , Pikulski  PJ , Tein  JY , Drake  KL .  School-Based Treatment for Anxiety Research Study (STARS): a randomized controlled effectiveness trial.   J Abnorm Child Psychol. 2020;48(3):407-417. doi:10.1007/s10802-019-00596-5PubMedGoogle ScholarCrossref
47.
Asbrand  J , Heinrichs  N , Schmidtendorf  S , Nitschke  K , Tuschen-Caffier  B .  Experience versus report: where are changes seen after exposure-based cognitive-behavioral therapy? a randomized controlled group treatment of childhood social anxiety disorder.   Child Psychiatry Hum Dev. 2020;51(3):427-441. doi:10.1007/s10578-019-00954-wPubMedGoogle ScholarCrossref
48.
Pine  DS , Walkup  JT , Labellarte  MJ ,  et al; Research Units on Pediatric Psychopharmacology Anxiety Study Group.  Fluvoxamine for the treatment of anxiety disorders in children and adolescents.   N Engl J Med. 2001;344(17):1279-1285. doi:10.1056/NEJM200104263441703PubMedGoogle ScholarCrossref
49.
Walkup  JT , Labellarte  MJ , Riddle  MA ,  et al; Research Units on Pediatric Psychopharmacology Anxiety Study Group.  Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders.   J Am Acad Child Adolesc Psychiatry. 2003;42(1):13-21. doi:10.1097/00004583-200301000-00006PubMedGoogle ScholarCrossref
50.
Ginsburg  GS , Riddle  MA , Davies  M .  Somatic symptoms in children and adolescents with anxiety disorders.   J Am Acad Child Adolesc Psychiatry. 2006;45(10):1179-1187. doi:10.1097/01.chi.0000231974.43966.6ePubMedGoogle ScholarCrossref
51.
Reinblatt  SP , DosReis  S , Walkup  JT , Riddle  MA .  Activation adverse events induced by the selective serotonin reuptake inhibitor fluvoxamine in children and adolescents.   J Child Adolesc Psychopharmacol. 2009;19(2):119-126. doi:10.1089/cap.2008.040PubMedGoogle ScholarCrossref
52.
Thirlwall  K , Cooper  PJ , Karalus  J , Voysey  M , Willetts  L , Creswell  C .  Treatment of child anxiety disorders via guided parent-delivered cognitive-behavioural therapy: randomised controlled trial.   Br J Psychiatry. 2013;203(6):436-444. doi:10.1192/bjp.bp.113.126698PubMedGoogle ScholarCrossref
53.
Perrin  S , Bevan  D , Payne  S , Bolton  D .  GAD-specific cognitive behavioral treatment for children and adolescents: a pilot randomized controlled trial.   Cognit Ther Res. 2019;43:1051-1064. doi:10.1007/s10608-019-10020-3Google ScholarCrossref
54.
Waite  P , Marshall  T , Creswell  C .  A randomized controlled trial of internet-delivered cognitive behaviour therapy for adolescent anxiety disorders in a routine clinical care setting with and without parent sessions.   Child Adolesc Ment Health. 2019;24(3):242-250. doi:10.1111/camh.12311PubMedGoogle ScholarCrossref
55.
Lau  WY , Chan  CK-y , Li  JC , Au  TK .  Effectiveness of group cognitive-behavioral treatment for childhood anxiety in community clinics.   Behav Res Ther. 2010;48(11):1067-1077. doi:10.1016/j.brat.2010.07.007PubMedGoogle ScholarCrossref
56.
Lyneham  HJ , Rapee  RM .  Evaluation of therapist-supported parent-implemented CBT for anxiety disorders in rural children.   Behav Res Ther. 2006;44(9):1287-1300. doi:10.1016/j.brat.2005.09.009PubMedGoogle ScholarCrossref
57.
Rudy  BM , Zavrou  S , Johnco  C , Storch  EA , Lewin  AB .  Parent-led exposure therapy: a pilot study of a brief behavioral treatment for anxiety in young children.   J Child Fam Stud. 2017;26(9):2475-2484. doi:10.1007/s10826-017-0772-yGoogle ScholarCrossref
58.
Villabø  MA , Narayanan  M , Compton  SN , Kendall  PC , Neumer  S-P .  Cognitive-behavioral therapy for youth anxiety: an effectiveness evaluation in community practice.   J Consult Clin Psychol. 2018;86(9):751-764. doi:10.1037/ccp0000326PubMedGoogle ScholarCrossref
59.
Arendt  K , Thastum  M , Hougaard  E .  Efficacy of a Danish version of the Cool Kids program: a randomized wait-list controlled trial.   Acta Psychiatr Scand. 2016;133(2):109-121. doi:10.1111/acps.12448PubMedGoogle ScholarCrossref
60.
Öst  L-G , Cederlund  R , Reuterskiöld  L .  Behavioral treatment of social phobia in youth: does parent education training improve the outcome?   Behav Res Ther. 2015;67:19-29. doi:10.1016/j.brat.2015.02.001PubMedGoogle ScholarCrossref
61.
Black  B , Uhde  TW .  Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study.   J Am Acad Child Adolesc Psychiatry. 1994;33(7):1000-1006. doi:10.1097/00004583-199409000-00010PubMedGoogle ScholarCrossref
62.
Birmaher  B , Axelson  DA , Monk  K ,  et al.  Fluoxetine for the treatment of childhood anxiety disorders.   J Am Acad Child Adolesc Psychiatry. 2003;42(4):415-423. doi:10.1097/01.CHI.0000037049.04952.9FPubMedGoogle ScholarCrossref
63.
Rynn  MA , Siqueland  L , Rickels  K .  Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder.   Am J Psychiatry. 2001;158(12):2008-2014. doi:10.1176/appi.ajp.158.12.2008PubMedGoogle ScholarCrossref
64.
Barrett  PM , Dadds  MR , Rapee  RM .  Family treatment of childhood anxiety: a controlled trial.   J Consult Clin Psychol. 1996;64(2):333-342. doi:10.1037/0022-006X.64.2.333PubMedGoogle ScholarCrossref
65.
Holmes  MC , Donovan  CL , Farrell  LJ , March  S .  The efficacy of a group-based, disorder-specific treatment program for childhood GAD—a randomized controlled trial.   Behav Res Ther. 2014;61:122-135. doi:10.1016/j.brat.2014.08.002PubMedGoogle ScholarCrossref
66.
Hirshfeld-Becker  DR , Masek  B , Henin  A ,  et al.  Cognitive behavioral therapy for 4- to 7-year-old children with anxiety disorders: a randomized clinical trial.   J Consult Clin Psychol. 2010;78(4):498-510. doi:10.1037/a0019055PubMedGoogle ScholarCrossref
67.
Shortt  AL , Barrett  PM , Fox  TL .  Evaluating the FRIENDS program: a cognitive-behavioral group treatment for anxious children and their parents.   J Clin Child Psychol. 2001;30(4):525-535. doi:10.1207/S15374424JCCP3004_09PubMedGoogle ScholarCrossref
68.
Donovan  CL , March  S .  Online CBT for preschool anxiety disorders: a randomised control trial.   Behav Res Ther. 2014;58:24-35. doi:10.1016/j.brat.2014.05.001PubMedGoogle ScholarCrossref
69.
Sánchez-García  R , Olivares Rodríguez  J .  Effectiveness of a program for early detection/intervention in children/adolescents with generalized social phobia.   An Psicol. Published December 2009. Accessed August 31, 2022. https://www.researchgate.net/publication/46171908_Effectiveness_of_a_program_for_early_detectionintervention_in_childrenadolescents_with_generalized_social_phobiaGoogle Scholar
70.
Strawn  JR , Mills  JA , Schroeder  H ,  et al.  Escitalopram in adolescents with generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.   J Clin Psychiatry. 2020;81(5):20m13396. doi:10.4088/JCP.20m13396PubMedGoogle ScholarCrossref
71.
O’Connor  E , Senger  CA , Henninger  M , Gaynes  BN , Coppola  E , Soulsby Weyrich  M .  US Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Interventions to Prevent Perinatal Depression: A Systematic Evidence Review for the US Preventive Services Task Force. Agency for Healthcare Research and Quality; 2019.
72.
Mammarella  IC , Donolato  E , Caviola  S , Giofrè  D .  Anxiety profiles and protective factors: a latent profile analysis in children.   Pers Individ Dif. 2018;124:201-208. doi:10.1016/j.paid.2017.12.017Google ScholarCrossref
73.
Osimo  EF , Stochl  J , Zammit  S , Lewis  G , Jones  PB , Khandaker  GM .  Longitudinal population subgroups of CRP and risk of depression in the ALSPAC birth cohort.   Compr Psychiatry. 2020;96:152143. doi:10.1016/j.comppsych.2019.152143PubMedGoogle ScholarCrossref
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close